Logo image of SRGA

SURGALIGN HOLDINGS INC (SRGA) Stock Price, Forecast & Analysis

USA - NASDAQ:SRGA - US86882C2044 - Common Stock

0.1829 USD
-0.09 (-32.98%)
Last: 6/30/2023, 8:00:01 PM
0.1235 USD
-0.06 (-32.48%)
After Hours: 6/30/2023, 8:00:01 PM

SRGA Key Statistics, Chart & Performance

Key Statistics
Market Cap1.68M
Revenue(TTM)78.12M
Net Income(TTM)-50.49M
Shares9.18M
Float8.21M
52 Week High6.77
52 Week Low0.17
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-5.81
PEN/A
Fwd PEN/A
Earnings (Next)08-07 2023-08-07/amc
IPO2000-08-10
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Supplies


SRGA short term performance overview.The bars show the price performance of SRGA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

SRGA long term performance overview.The bars show the price performance of SRGA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of SRGA is 0.1829 USD. In the past month the price decreased by -75.93%. In the past year, price decreased by -94.35%.

SURGALIGN HOLDINGS INC / SRGA Daily stock chart

SRGA Latest News, Press Relases and Analysis

SRGA Competitors/Peers

The largest stocks on the US markets in the "Health Care Supplies" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
COO COOPER COS INC/THE 17.85 14.27B
SOLV SOLVENTUM CORP 12.72 13.10B
ALGN ALIGN TECHNOLOGY INC 14 9.81B
MMSI MERIT MEDICAL SYSTEMS INC 22.99 5.07B
LNTH LANTHEUS HOLDINGS INC 8.78 3.56B
HAE HAEMONETICS CORP/MASS 15.28 3.53B
ICUI ICU MEDICAL INC 17.02 3.35B
XRAY DENTSPLY SIRONA INC 6.66 2.10B
UFPT UFP TECHNOLOGIES INC 26.52 1.76B
NEOG NEOGEN CORP 21.13 1.38B
STAA STAAR SURGICAL CO N/A 1.30B
EMBC EMBECTA CORP 4.9 837.58M

About SRGA

Company Profile

SRGA logo image Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. The company is headquartered in Deerfield, Illinois and currently employs 217 full-time employees. The company went IPO on 2000-08-10. The firm is focused on developing artificial intelligence (AI) and augmented reality (AR) technology platform called HOLO AI, which is an AI software technology, which connects the continuum of care from the pre-op and clinical-stage through post-op care. Its HOLO Portal surgical guidance system, a component of its HOLO AI technology platform, is designed to automatically recognize, identify, and segment patient anatomy to autonomously assist the surgeon throughout the surgical procedure. The company has a portfolio of spinal hardware implants, including solutions for fusion procedures in the lumbar, thoracic, and cervical spine, motion, and a minimally invasive surgical implant system for fusion of the sacroiliac joint. The company also has a biomaterials portfolio of advanced and traditional orthobiologics. Its market and sell products to hospitals, ambulatory surgery centers, and healthcare providers in the United States.

Company Info

SURGALIGN HOLDINGS INC

520 Lake Cook Rd Ste 315

Deerfield ILLINOIS 60015 US

CEO: Terry M. Rich

Employees: 217

SRGA Company Website

Phone: 18773436832.0

SURGALIGN HOLDINGS INC / SRGA FAQ

Can you describe the business of SURGALIGN HOLDINGS INC?

Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. The company is headquartered in Deerfield, Illinois and currently employs 217 full-time employees. The company went IPO on 2000-08-10. The firm is focused on developing artificial intelligence (AI) and augmented reality (AR) technology platform called HOLO AI, which is an AI software technology, which connects the continuum of care from the pre-op and clinical-stage through post-op care. Its HOLO Portal surgical guidance system, a component of its HOLO AI technology platform, is designed to automatically recognize, identify, and segment patient anatomy to autonomously assist the surgeon throughout the surgical procedure. The company has a portfolio of spinal hardware implants, including solutions for fusion procedures in the lumbar, thoracic, and cervical spine, motion, and a minimally invasive surgical implant system for fusion of the sacroiliac joint. The company also has a biomaterials portfolio of advanced and traditional orthobiologics. Its market and sell products to hospitals, ambulatory surgery centers, and healthcare providers in the United States.


Can you provide the latest stock price for SURGALIGN HOLDINGS INC?

The current stock price of SRGA is 0.1829 USD. The price decreased by -32.98% in the last trading session.


Does SRGA stock pay dividends?

SRGA does not pay a dividend.


What is the ChartMill rating of SURGALIGN HOLDINGS INC stock?

SRGA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


What is the analyst forecast for SRGA stock?

10 analysts have analysed SRGA and the average price target is 2.3 USD. This implies a price increase of 1154.78% is expected in the next year compared to the current price of 0.1829.


What is the employee count for SRGA stock?

SURGALIGN HOLDINGS INC (SRGA) currently has 217 employees.


What is SURGALIGN HOLDINGS INC worth?

SURGALIGN HOLDINGS INC (SRGA) has a market capitalization of 1.68M USD. This makes SRGA a Nano Cap stock.


SRGA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

SRGA Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to SRGA. SRGA has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SRGA Financial Highlights

Over the last trailing twelve months SRGA reported a non-GAAP Earnings per Share(EPS) of -5.81. The EPS increased by 50.34% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%57.14%
Sales Q2Q%-18.72%
EPS 1Y (TTM)50.34%
Revenue 1Y (TTM)-11.04%

SRGA Forecast & Estimates

10 analysts have analysed SRGA and the average price target is 2.3 USD. This implies a price increase of 1154.78% is expected in the next year compared to the current price of 0.1829.

For the next year, analysts expect an EPS growth of -58.25% and a revenue growth -37.13% for SRGA


Analysts
Analysts82
Price Target2.3 (1157.52%)
EPS Next Y-58.25%
Revenue Next Year-37.13%

SRGA Ownership

Ownership
Inst Owners0%
Ins Owners110.88%
Short Float %N/A
Short RatioN/A